the present invention relates , in part , to the discovery that a pharmaceutical composition comprising aripiprazole and a carrier administered in a bolus injection resulted in an extended release profile similar to that obtained by the injection of a poly lactide - co - glycolide microsphere formulation containing the active agent . this surprising result suggests that pharmacologically beneficial extended release formulations without the complexities and expense associated with the manufacture microspheres .